本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Context Therapeutics Inc.

0.3644
+0.01343.82%
盤前0.3577-0.0067-1.84%08:15 EDT
成交量:137.65萬
成交額:49.83萬
市值:3,348.08萬
市盈率:-0.75
高:0.3830
開:0.3643
低:0.3512
收:0.3510
52周最高:3.62
52周最低:0.3434
股本:9,187.92萬
流通股本:6,373.36萬
量比:1.29
換手率:2.16%
股息:- -
股息率:- -
每股收益(TTM):-0.4828
每股收益(LYR):-0.3800
淨資產收益率:-76.14%
總資產收益率:-45.70%
市淨率:0.88
市盈率(LYR):-0.96

資料載入中...

2022/01/05

重要事件披露

8-K - Current report
2021/12/14

SEC問詢函

CORRESP [Cover] - Correspondence
2021/12/10

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/11/01

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/11/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/25

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/25

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/25

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/22

重要事件披露

8-K - Current report
2021/10/20

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/18

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/18

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/10/15

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/15

SEC問詢函

CORRESP [Cover] - Correspondence
2021/09/29

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/29

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/09/24

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/24

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/09/24

SEC問詢函

CORRESP [Cover] - Correspondence
2021/09/13

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933